HC

Hitesh Chauhan

Active Director Director DIN 11104654
DIN 11104654 First appointment May 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Hitesh Chauhan

Data last updated:

Hitesh Chauhan is a Director at Curezenix Pharma Private Limited (since 2025) and Director at Tavasya Delhi Foundation (since 2025).

DIN 11104654
Primary Designation Director
First Appointment 13 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Curezenix Pharma Private Limited U47721DL2025PTC451484
Director08 Jul 20252025Active
Tavasya Delhi Foundation U88900DL2025NPL448220
Director13 May 20252025Active

Board colleagues of Hitesh Chauhan

Directorship timeline

Open interactive timeline →
Curezenix Pharma Private Limited
Tavasya Delhi Foundation
Premium access

Shareholding and investment profile for Hitesh Chauhan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hitesh Chauhan

Hitesh Chauhan currently holds 2 directorships: Curezenix Pharma Private Limited (Director, since 08 Jul 2025); Tavasya Delhi Foundation (Director, since 13 May 2025).

Hitesh Chauhan was first appointed on 13 May 2025 as Director at Tavasya Delhi Foundation.

The current boards of Hitesh Chauhan's companies include Sachin Maggo (Curezenix Pharma Private Limited), Vishal Kayath (Curezenix Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available